Based on our findings of suppression of pancreatic cancer, and inhibition of AKT pathway and induction of JNK pathway mediated by rhoifolin, we further verified whether rhoifolin could influence pancreatic cancer progression by changing the expression of AKT or JNK pathways. This evidence concerns the gene AKT1 and pancreatic neoplasm.